SESN2 and nasopharyngeal carcinoma: Furthermore, it is unclear whether sestrin 2 acts as a tumor suppressor or promoter in thyroid cancer, head and neck cancer, neuroblastoma, and nasopharyngeal carcinoma, and verification requires more data.